NBTXR3 plus radiotherapy did not negatively affect quality of life or long-term morbidity in locally advanced soft tissue sarcoma.
Researchers found that lack of radiosensitivity was associated with poor outcomes in patients with myxoid liposarcomas.
Neoadjuvant and adjuvant radiotherapy were associated with a reduced risk of local recurrence.
Most patients included in the retrospective analysis received ICI treatment as their first line of therapy (59%).
Stable disease was observed in 51.3% of patients.
Amputation was significantly more likely in patients with household incomes below $75,000 per year.
The hospitalization rate was 49%, and 16% of patients died.
The 24-month overall survival rate was 42.8%.